Skip to main navigation Skip to search Skip to main content

Open source drug discovery: Highly potent antimalarial compounds derived from the tres cantos arylpyrroles

  • Alice E. Williamson
  • , Paul M. Ylioja
  • , Murray N. Robertson
  • , Vicky Avery
  • , Jonathan B. Baell
  • , Harikrishna Batchu
  • , Sanjay Batra
  • , Jeremy N. Burrows
  • , Soumya Bhattacharyya
  • , Felix Calderon
  • , Susan A. Charman
  • , Julie Clark
  • , Benigno Crespo
  • , Matin Dean
  • , Stefan L. Debbert
  • , Michael Delves
  • , Adelaide S.M. Dennis
  • , Frederik Deroose
  • , Sandra Duffy
  • , Sabine Fletcher
  • Guri Giaever, Irene Hallyburton, Francisco Javier Gamo, Marinella Gebbia, R. Kiplin Guy, Zoe Hungerford, Kiaran Kirk, Maria J. Lafuente-Monasterio, Anna Lee, Stephan Meister, Corey Nislow, John P. Overington, George Papadatos, Luc Patiny, James Pham, Stuart A. Ralph, Andrea Ruecker, Eileen Ryan, Christopher Southan, Kumkum Srivastava, Chris Swain, Matthew J. Tarnowski, Patrick Thomson, Peter Turner, Iain M. Wallace, Timothy N.C. Wells, Karen White, Laura White, Paul Willis, Elizabeth A. Winzeler, Sergio Wittlin, Matthew H. Todd, Yevgeniya Antonova-Koch
  • University of Sydney
  • Griffith University Queensland
  • Monash University
  • CSIR - Central Drug Research Institute
  • Medicines for Malaria Venture
  • GlaxoSmithKline
  • St. Jude Children Research Hospital
  • Lawrence University
  • Imperial College London
  • Australian National University
  • Asclepia Outsourcing Solutions
  • University of Toronto
  • University of Dundee
  • University of California at San Diego
  • Wellcome Trust
  • Swiss Federal Institute of Technology Lausanne
  • University of Melbourne
  • University of Edinburgh
  • Cambridge MedChem Consulting
  • Merck
  • Swiss Tropical and Public Health Institute

Research output: Contribution to journalArticlepeer-review

Abstract

The development of new antimalarial compounds remains a pivotal part of the strategy for malaria elimination. Recent large-scale phenotypic screens have provided a wealth of potential starting points for hit-to-lead campaigns. One such public set is explored, employing an open source research mechanism in which all data and ideas were shared in real time, anyone was able to participate, and patents were not sought. One chemical subseries was found to exhibit oral activity but contained a labile ester that could not be replaced without loss of activity, and the original hit exhibited remarkable sensitivity to minor structural change. A second subseries displayed high potency, including activity within gametocyte and liver stage assays, but at the cost of low solubility. As an open source research project, unexplored avenues are clearly identified and may be explored further by the community; new findings may be cumulatively added to the present work.

Original languageEnglish
Pages (from-to)687-701
Number of pages15
JournalACS Central Science
Volume2
Issue number10
DOIs
Publication statusPublished - 26 Oct 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Open source drug discovery: Highly potent antimalarial compounds derived from the tres cantos arylpyrroles'. Together they form a unique fingerprint.

Cite this